Targovax ASA logo

TRVXo - Targovax ASA News Story

NOK6.38 -0.0  -0.6%

Last Trade - 10/08/20

Sector
Healthcare
Size
Micro Cap
Market Cap £41.3m
Enterprise Value £35.7m
Revenue £217k
Position in Universe 1012th / 1782

BRIEF-Targovax Enters Collaboration With Leidos

Thu 4th June, 2020 7:02am
June 4 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX ENTERS COLLABORATION WITH LEIDOS TO ADD
CHECKPOINT
INHIBITOR FUNCTIONALITY TO ONCOS VIRUSES
    * UNDER AGREEMENT, LEIDOS AND TARGOVAX WILL INVESTIGATE
TECHNICAL
FEASIBILITY, IN VITRO AND IN VIVO IMMUNE MODULATORY, AND
ANTI-CANCER PROPERTIES OF ENCODING MICROTIDE™ CHECKPOINT
PEPTIDES IN ONCOS ADENOVIRUS BACKBONE
    * IF SUCCESSFUL, COMBINED ONCOS AND MICROTIDE™ CONSTRUCTS
MAY
SERVE AS A PLATFORM WHERE ADDITIONAL FUNCTIONALITY CAN BE BUILT
IN TO STIMULATE MULTIPLE COMPLEMENTARY ANTI-TUMOR MECHANISMS

Source text for Eikon:  ID:nWkr8xVgcD 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.